It is straight forward really,
NNZ 2591 for RETT and Fragile X world wide is owned by ACADIA and pay royalties to Neuren.
NNZ2591 used for other diseases such as THE CURRENT 4 TRIALS NEU are doing will be owned exclusively by NEU.
BP van take over Neuren and have world rights to NNZ 2591 and recieve royalties from ACADIA for Rett Syndrome/ Daybue sales and fragile X when that eventuates.
- Forums
- ASX - By Stock
- ANAVEX MEETS ENDPOINTS PHASE2 RETT
It is straight forward really,NNZ 2591 for RETT and Fragile X...
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.61 |
Change
0.010(0.06%) |
Mkt cap ! $1.995B |
Open | High | Low | Value | Volume |
$15.64 | $15.93 | $15.44 | $8.412M | 538.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 558 | $15.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.66 | 1841 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 558 | 15.590 |
1 | 100 | 15.580 |
1 | 64 | 15.550 |
1 | 3405 | 15.520 |
3 | 3288 | 15.510 |
Price($) | Vol. | No. |
---|---|---|
15.660 | 1841 | 1 |
15.680 | 1447 | 2 |
15.690 | 1841 | 1 |
15.720 | 1841 | 1 |
15.730 | 2500 | 1 |
Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online